GBC Blog

DETROIT & ROYSTON, U.K., July 11, 2017 /EINPresswire.com/ — Asterand Bioscience, the leader in high quality, well-characterized human tissue and human tissue-based research solutions supporting drug discovery and development, announced today the introduction of the PerkinElmer Vectra® Polaris™ Automated Quantitative Pathology Imaging System to extend their services capabilities to support scientists in gaining a deeper understanding…

Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits – Several ECCMID 2017 presentations highlight advantages of rapid time to result with Unyvero ITI in Prosthetic Joint Infections Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 27, 2017 – Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a developer…

Epigenomics Agrees to Takeover Bid Apr 26, 2017  NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics announced today that it has agreed to a public takeover offer from Blitz F16-83, a subsidiary of Chinese private equity firm Cathay Fortune International. Under the terms of the deal, Epigenomics shareholders will be offered €7.52 ($8.19) in…

Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking – Product to launch in EMEA at ECCMID Conference April 22-25, 2017 – IAI Panel covers up to 130 diagnostic targets Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 20, 2017 – Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular…

Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe – U.S. data set complemented by recent clinical study data from European hospital Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 10, 2017 — Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a developer of next-level molecular diagnostic solutions, today…

  FDA Approves 23andMe’s Genetic Test for Personal Disease Risks – Agency stresses that product labeling should show test not designed to diagnose, determine treatment or say anything about user’s state of health Wall Street Journal, April 6, 2017 5:47 p.m. ET Food and Drug Administration approved the first-ever direct-to-consumer genetic testing for people’s personal…

Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing – Successful completion of GEAR asset and know how transfer from Siemens to Curetis Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 6, 2017 — Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that…

Computational Biologists Predict Antibiotic Resistances Using Biotech March 10, 2017 06:47 ET | Source: Curetis GmbH Every year, some 25,000 people die in the European Union from antibiotic-resistant, hard to treat bacteria. Although there are diagnostic methods in place to recognize such resistances in advance, these are typically very time-consuming. Researchers from the Center for…

U.S. Department of Veterans Affairs Awards Supply Contract for Epi proColon Berlin (Germany) and Germantown, MD (U.S.A.), March 3, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), today announced that the U.S. Department of Veterans Affairs has awarded Epigenomics’ distribution partner Polymedco, Inc. with a five-year supply contract for Epi proColon, commencing March…

Epigenomics Joins Forces with hundreds of Organizations to Increase Colorectal Cancer Screening Rates in the United States “80% by 2018” is a shared goal to have 80% of adults aged 50 and older screened for colorectal cancer by 2018 – Colorectal cancer screening has been proven to save lives Berlin (Germany) and Germantown, MD (U.S.A.),…